Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singer, B. B.
Right arrow Articles by Öbrink, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singer, B. B.
Right arrow Articles by Öbrink, B.
[Cancer Research 60, 1236-1244, March 1, 2000]
© 2000 American Association for Cancer Research

Biochemistry and Biophysics

The Tumor Growth-inhibiting Cell Adhesion Molecule CEACAM1 (C-CAM) Is Differently Expressed in Proliferating and Quiescent Epithelial Cells and Regulates Cell Proliferation1

Bernhard B. Singer, Inka Scheffrahn and Björn Öbrink2

Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, SE-171 77 Stockholm, Sweden

The homophilic cell adhesion molecule CEACAM1 (C-CAM, BGP, CD66a) occurs as two coexpressed isoforms, CEACAM1-L and CEACAM1-S, in epithelia, endothelia, and leukocytes. CEACAM1-L can inhibit tumor growth; this effect is influenced by CEACAM1-S. To characterize the growth regulatory properties of CEACAM1, we analyzed the expression patterns of the isoforms, and here we demonstrate that both the expression levels and the S:L isoform ratios differ in proliferating and quiescent rat epithelial cells. Quiescent prostate NbE cells expressed more CEACAM1 than quiescent bladder NBT-II cells, a pattern that correlated with the expression levels in the parental tissues. In contrast, both the expression levels and the isoform ratios were strikingly similar in proliferating NbE and NBT-II cells, showing that a particular CEACAM1 expression pattern is compatible with cell proliferation. However, in confluent cells, CEACAM1 seemed to exert inhibitory effects on cell proliferation. Addition of anti-CEACAM1 antibodies to quiescent, confluent cells caused decreased expression of the cyclin-dependent kinase inhibitor, p27Kip1, stimulated growth factor-dependent DNA synthesis, and altered the S:L isoform ratio toward the ratio characteristic of proliferating cells. Taken together, our data suggest that CEACAM1 contributes to contact inhibition of cell proliferation in confluent cells but allows proliferation when expressed at different isoform ratios.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
E. Klaile, M. M. Muller, C. Kannicht, W. Otto, B. B. Singer, W. Reutter, B. Obrink, and L. Lucka
The Cell Adhesion Receptor Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 Regulates Nucleocytoplasmic Trafficking of DNA Polymerase {delta}-Interacting Protein 38
J. Biol. Chem., September 7, 2007; 282(36): 26629 - 26640.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Yu, E. M. C. Chow, H. Wong, J. Gu, O. Mandelboim, S. D. Gray-Owen, and M. A. Ostrowski
CEACAM1 (CD66a) Promotes Human Monocyte Survival via a Phosphatidylinositol 3-Kinase- and AKT-dependent Pathway
J. Biol. Chem., December 22, 2006; 281(51): 39179 - 39193.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
L. O'Driscoll, P. Gammell, E. McKiernan, E. Ryan, P. B. Jeppesen, S. Rani, and M. Clynes
Phenotypic and global gene expression profile changes between low passage and high passage MIN-6 cells
J. Endocrinol., December 1, 2006; 191(3): 665 - 676.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
B. Albarran-Somoza, R. Franco-Topete, V. Delgado-Rizo, F. Cerda-Camacho, L. Acosta-Jimenez, M. Lopez-Botet, and A. Daneri-Navarro
CEACAM1 in Cervical Cancer and Precursor Lesions: Association With Human Papillomavirus Infection
J. Histochem. Cytochem., December 1, 2006; 54(12): 1393 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
T. NAGAISHI, H. IIJIMA, A. NAKAJIMA, D. CHEN, and R. S BLUMBERG
Role of CEACAM1 as a Regulator of T Cells.
Ann. N.Y. Acad. Sci., August 1, 2006; 1072: 155 - 175.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. M. Muller, B. B. Singer, E. Klaile, B. Obrink, and L. Lucka
Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells
Blood, May 15, 2005; 105(10): 3925 - 3934.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. L. Servin
Pathogenesis of Afa/Dr Diffusely Adhering Escherichia coli
Clin. Microbiol. Rev., April 1, 2005; 18(2): 264 - 292.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Kilic, L. Oliveira-Ferrer, J.-H. Wurmbach, S. Loges, F. Chalajour, S. N. Vahid, J. Weil, M. Fernando, and S. Ergun
Pro-angiogenic Signaling by the Endothelial Presence of CEACAM1
J. Biol. Chem., January 21, 2005; 280(3): 2361 - 2369.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
D.D. Bosshardt and N.P. Lang
The Junctional Epithelium: from Health to Disease
J. Dent. Res., January 1, 2005; 84(1): 9 - 20.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
L. Lucka, M. Fernando, D. Grunow, C. Kannicht, A. K. Horst, P. Nollau, and C. Wagener
Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes
Glycobiology, January 1, 2005; 15(1): 87 - 100.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Oliveira-Ferrer, D. Tilki, G. Ziegeler, J. Hauschild, S. Loges, S. Irmak, E. Kilic, H. Huland, M. Friedrich, and S. Ergun
Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Angiogenesis and Invasion of Human Urinary Bladder Cancer
Cancer Res., December 15, 2004; 64(24): 8932 - 8938.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
H. Lauke, N. Kilic, R. Bozorgzad, M. Fernando, S. Neshat-Vahid, T. Pottek, and S. Ergun
Expression of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) in normal human Sertoli cells and its up-regulation in impaired spermatogenesis
Mol. Hum. Reprod., April 1, 2004; 10(4): 247 - 252.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
U. Sundberg, N. Beauchemin, and B. Obrink
The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells
J. Cell Sci., March 1, 2004; 117(7): 1091 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
B. Fournes, J. Farrah, M. Olson, N. Lamarche-Vane, and N. Beauchemin
Distinct Rho GTPase Activities Regulate Epithelial Cell Localization of the Adhesion Molecule CEACAM1: Involvement of the CEACAM1 Transmembrane Domain
Mol. Cell. Biol., October 15, 2003; 23(20): 7291 - 7304.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
G. Greicius, E. Severinson, N. Beauchemin, B. Obrink, and B. B. Singer
CEACAM1 is a potent regulator of B cell receptor complex-induced activation
J. Leukoc. Biol., July 1, 2003; 74(1): 126 - 134.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. Laack, H. Nikbakht, A. Peters, C. Kugler, Y. Jasiewicz, L. Edler, J. Brummer, U. Schumacher, and D. K. Hossfeld
Expression of CEACAM1 in Adenocarcinoma of the Lung: A Factor of Independent Prognostic Significance
J. Clin. Oncol., November 1, 2002; 20(21): 4279 - 4284.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
B. OBRINK, H. SAWA, I. SCHEFFRAHN, B. B. SINGER, K. SIGMUNDSSON, U. SUNDBERG, R. HEYMANN, N. BEAUCHEMIN, G. WENG, P. RAM, et al.
Computational Analysis of Isoform-Specific Signal Regulation by CEACAM1--A Cell Adhesion Molecule Expressed in PC12 Cells
Ann. N.Y. Acad. Sci., October 1, 2002; 971(1): 597 - 607.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. B. Singer, I. Scheffrahn, R. Heymann, K. Sigmundsson, R. Kammerer, and B. Obrink
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Expression and Signaling in Human, Mouse, and Rat Leukocytes: Evidence for Replacement of the Short Cytoplasmic Domain Isoform by Glycosylphosphatidylinositol-Linked Proteins in Human Leukocytes
J. Immunol., May 15, 2002; 168(10): 5139 - 5146.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
U. Sundberg and B. Obrink
CEACAM1 isoforms with different cytoplasmic domains show different localization, organization and adhesive properties in polarized epithelial cells
J. Cell Sci., March 15, 2002; 115(6): 1273 - 1284.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Brummer, A. Ebrahimnejad, R. Flayeh, U. Schumacher, T. Loning, A.-M. Bamberger, and C. Wagener
cis Interaction of the Cell Adhesion Molecule CEACAM1 with Integrin {beta}3
Am. J. Pathol., August 1, 2001; 159(2): 537 - 546.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
R. Kammerer, D. Stober, B. B. Singer, B. Obrink, and J. Reimann
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 on Murine Dendritic Cells Is a Potent Regulator of T Cell Stimulation
J. Immunol., June 1, 2001; 166(11): 6537 - 6544.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.